Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20251207068236N1Phase 4Completed
Phase 4, single-blind trial of budesonide, fluticasone and hypertonic saline in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Change in SNOT-22 score, Change in Visual Analog Scale symptom severity and 2 more. Started Nov 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20251207068236N1.